Polysomnography findings in pediatric spinal muscular atrophy types 1-3

被引:24
|
作者
Chacko, Archana [1 ,2 ]
Sly, Peter D. [2 ]
Gauld, Leanne [1 ,2 ]
机构
[1] Queensland Childrens Hosp, Brisbane, Qld, Australia
[2] Univ Queensland, Ctr Child Hlth Res, Brisbane, Qld, Australia
关键词
Pediatric spinal muscular atrophy; Polysomnography; Spinal muscular atrophy type one; Spinal muscular atrophy type two; Spinal muscular atrophy type three; NONINVASIVE VENTILATION; SLEEP ARCHITECTURE; CHILDREN; INFANTS; DISEASE; VALUES; MANAGEMENT; DISORDERS; PULMONARY; MECHANICS;
D O I
10.1016/j.sleep.2019.12.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sleep disordered breathing (SDB) causes sleep disturbance and daytime symptoms in children with neuromuscular disorders. Although polysomnography (PSG) findings are well described in many neuromuscular disorders, there are limited reports from children with spinal muscular atrophy (SMA). The aim of this study was to determine the sleep architecture and breathing characteristics and non-invasive ventilation (NIV) use in our pediatric SMA cohort. Methods: We conducted a cross-sectional cohort study of all children with SMA in Queensland, Australia. Children were Nusinersen naive and had a full diagnostic PSG in 2018. The PSG was scored and reported by a single pediatric sleep physician in accordance with American Academy of Sleep Medicine Criteria (2012). Results: In sum, 31 children (18 males), Six with Type 1, 16 with Type 2 and nine with Type 3, aged 0.25-18.8 years old were studied. SDB was seen in each SMA type and was more pronounced during rapid eye movement ( REM) sleep. Type 1: all patients exhibited SDB, three (50%) with central sleep apnea (CSA) and three (50%) with mixed disease. Type 2: five (31%) had CSA, one (6%) mixed disease, seven (44%) had early SDB and three (19%) had normal sleep breathing. Type 3: four (44%) children had CSA and five had early SDB. No child exhibited obstructive sleep apnea (OSA) alone.Starting NIV significantly reduced mean total PSG Apnea-Hypopnea Index (AHI) scores from a grouped mean of 15.4 events per hour (SD +/- 14.6; 95% CI 6.1-24.7) to 4.0 events per hour (SD +/- 4.2, 95% CI 1.2-6.5, p = 0.01). Conclusion: SDB is common in children with SMA and was present in all types. CSA was the most common disorder; with mixed SDB also present in type 1 and 2 SMA. (C) 2019 Published by Elsevier B.V.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 50 条
  • [31] Genetic findings of Cypriot spinal muscular atrophy patients
    Theodorou, L.
    Nicolaou, P.
    Koutsou, P.
    Georghiou, A.
    Anastasiadou, V.
    Tanteles, G.
    Kyriakides, T.
    Zamba-Papanicolaou, E.
    Christodoulou, K.
    NEUROLOGICAL SCIENCES, 2015, 36 (10) : 1829 - 1834
  • [32] Genetic findings of Cypriot spinal muscular atrophy patients
    L. Theodorou
    P. Nicolaou
    P. Koutsou
    A. Georghiou
    V. Anastasiadou
    G. Tanteles
    T. Kyriakides
    E. Zamba-Papanicolaou
    K. Christodoulou
    Neurological Sciences, 2015, 36 : 1829 - 1834
  • [33] Sleep-disordered breathing in spinal muscular atrophy types 1 and 2
    Testa, MBC
    Pavone, M
    Bertini, E
    Petrone, A
    Pagani, M
    Cutrera, R
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (09) : 666 - 670
  • [34] Drug treatment in spinal muscular atrophy types 1, 2 and 3: An update of the systematic Cochrane review
    Wadman, R. I.
    van der Pol, W. L.
    Vrancken, A. F. J.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 686 - 686
  • [35] Core Outcome Set for Pediatric Spinal Muscular Atrophy
    Iraqi, I.
    Ng, P.
    Desautels, C.
    Clegg, J.
    Cushen, N.
    Fiscaletti, M.
    Gonorazky, H.
    Haldenby, R.
    Hodgkinson, V
    Jaworski, M.
    Mackenzie, A.
    McMillan, H.
    Mortenson, P.
    Hj, Osman
    Potter, B.
    Round, J.
    Seguin, O.
    Selby, K.
    Sheriko, J.
    Smith, M.
    Oskoui, M.
    ANNALS OF NEUROLOGY, 2025, 96 : S145 - S145
  • [36] Serum leptin levels in children and adolescents with spinal muscular atrophy types 2 and 3
    Djordjevic, S.
    Milic-Rasic, V
    Brankovic, V
    Kosac, A.
    Dejanovic-Djordjevic, I
    Bijelic, M.
    Dimkic-Tomic, T.
    Markovic-Denic, Lj
    Kovacevic, S.
    Petrovic, H.
    Vitorovic, S.
    Dobric, Z.
    Zdravkovic, V
    ARCHIVES DE PEDIATRIE, 2022, 29 (07): : 480 - 483
  • [37] Prospective cohort study of spinal muscular atrophy types 2 and 3 in Spanish population
    Natera-de Benito, D.
    Alarcon, M.
    Borras, A.
    Armas, J.
    Frongia, A.
    Itzep, D.
    Vigo, M.
    Medina, J.
    Ortez, C.
    Colomer, J.
    Nascimento, A.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S132 - S132
  • [38] Drug treatment for spinal muscular atrophy types II and III
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van den Berg, Leonard H.
    wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [39] Drug treatment for spinal muscular atrophy types II and III
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van der Pol, W. Ludo
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [40] Drug treatment for spinal muscular atrophy types II and III
    Bosboom, Wendy M. J.
    Vrancken, Alexander F. J. E.
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):